Suppr超能文献

源自人脐带的替代异种无血清生物材料,用于间充质干细胞的体外自我更新扩增。

Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells.

机构信息

1 Department of Applied Bioscience, CHA University , Seongnam-si, South Korea .

出版信息

Stem Cells Dev. 2013 Nov 15;22(22):3025-38. doi: 10.1089/scd.2013.0067. Epub 2013 Jul 30.

Abstract

Mesenchymal stem cells (MSCs) are attractive candidates for novel cell-therapy applications. However, the in vitro expansion of MSCs typically depends on the presence of fetal bovine serum (FBS) and coating materials derived from animal sources, which may cause contamination in clinical applications. In this study, we investigated whether human umbilical cord extract (UCE) could serve as a serum replacement and whether collagen purified from umbilical cord (UC-collagen) could act as an extracellular matrix (ECM) for the in vitro culture of MSCs derived from human UC (UC-MSCs). A total of 5.61 ± 0.54 mg UCE and 18.41 ± 2.42 mg collagen were extracted, and 1.3 ± 0.2 × 10⁵ cells were isolated from 1 g of UC, as determined by the expression of typical MSC surface markers. Importantly, the proliferation and stemness of the UC-MSCs cultured with the UCE media were similar to those cultured under FBS conditions on UC-collagen-treated plates for eight passages. Based on these results, we suggest that UCs, which are discarded as medical waste, represent a viable alternative source of xeno-free biomaterials to replace animal-derived serum and ECM materials for the cultivation of various cell types, including UC-MSCs, adipose tissue-derived MSCs, bone marrow-derived MSCs, and fibroblasts. This innovative xeno-free MSCs culture system can overcome many of the problems associated with immunogenicity, and it will further contribute to the enhancement of treatment efficiency.

摘要

间充质干细胞(MSCs)是新型细胞治疗应用的有吸引力的候选者。然而,MSCs 的体外扩增通常依赖于胎牛血清(FBS)和源自动物来源的涂层材料的存在,这可能在临床应用中引起污染。在这项研究中,我们研究了人脐带提取物(UCE)是否可以用作血清替代物,以及是否从脐带中纯化的胶原蛋白(UC-胶原蛋白)可以作为人 UC 来源的 MSC(UC-MSCs)体外培养的细胞外基质(ECM)。通过典型 MSC 表面标志物的表达,总共提取了 5.61 ± 0.54 mg UCE 和 18.41 ± 2.42 mg 胶原蛋白,从 1 g UC 中分离出 1.3 ± 0.2 × 10⁵个细胞。重要的是,在用 UCE 培养基培养的 UC-MSCs 的增殖和干性与在 FBS 条件下在 UC-胶原蛋白处理板上培养的细胞相似,培养了 8 代。基于这些结果,我们建议将作为医疗废物丢弃的 UC 代表一种可行的无动物生物材料替代来源,以替代动物来源的血清和 ECM 材料,用于培养各种细胞类型,包括 UC-MSCs、脂肪组织来源的 MSCs、骨髓来源的 MSCs 和成纤维细胞。这种创新的无动物 MSCs 培养系统可以克服与免疫原性相关的许多问题,并进一步有助于提高治疗效率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验